Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Neurological and cognitive problems news

Show

From To
Hepatitis C ruled out as cause of mental impairment in HIV patients

“Hepatitis C infection has serious long-term side effects, such as damage to the liver, but our research indicates that it does not affect the brain,” said lead author David Clifford, MD, of Washington University.

Published
15 December 2014
From
Washington University press release
Immune cells proposed as HIV hideout don't last in primate model

The type of immune cell called macrophages, which have been proposed as a 'sanctuary site' of HIV in the brain and other organs, and as a possible cause of HIV-related brain impairment, don't live long enough to serve as reservoirs of HIV, a study in PLoS Pathogens finds.

Published
04 November 2014
From
EATG
HIV RNA lingers in CSF through up to 10 years of suppressive ART

HIV RNA remained detectable at low levels in cerebrospinal fluid (CSF) of almost 20% of patients who had HIV RNA levels below 40 copies/mL for up to 10 years of antiretroviral therapy (ART). The investigators believe their finding indicates that the central nervous system (CNS) can be an HIV reservoir during suppressive ART.

Published
28 October 2014
From
International AIDS Society
The First HIV/AIDS Generation Reaches Retirement Age

People with HIV and AIDS are living longer than was ever expected before the development of highly active antiretroviral therapies in the 1990s. Palm Springs, a Coachella Valley desert city 100 miles east of Los Angeles, has become a hub for older infected residents well into their 60s and 70s. Yet even as many live longer, there is a broad segment of HIV patients who are aging physically and cognitively faster than the rest of the population.

Published
22 September 2014
From
Newsweek
Why HIV patients develop dementia

Although HIV dos not infect nerve cells, researchers strongly suspect that, once activated in the brain and the spinal cord, immune cells keep up a chronic inflammation level which then results in the destruction of nerve cells.

Published
05 September 2014
From
EATG
Efavirenz use not linked to neurocognitive impairment

People who use antiretroviral regimens containing efavirenz (Sustiva or Stocrin, also in the Atripla coformulation) were not at higher risk for impaired neurocognitive function, either overall or when looking

Published
25 July 2014
By
Liz Highleyman
Study finds no evidence that HIV-positive gay men in UK have increased risk of neurocognitive impairment

Prevalence and severity of neurocognitive impairment does not differ between HIV-positive and HIV-negative gay men, UK investigators report in the online edition of the Journal of Acquired

Published
15 July 2014
By
Michael Carter
Common HIV Drug May Boost Suicide Risk

A medication commonly used to treat HIV appears to double the risk that patients will develop suicidal thoughts or take their lives, new research contends. The finding concerns the anti-HIV drug efavirenz, which is marketed as Sustiva.

Published
02 July 2014
From
Web MD
PI Therapy Raises Risk of Cerebral Small-Vessel Disease in US Group

Treatment with HIV protease inhibitors (PIs) heightened chances of cerebral small-vessel disease (CSVD) in a group of US adults. And mild CSVD raised chances of HIV-associated neurocognitive disorder (HAND).

Published
30 May 2014
From
International AIDS Society
PCR testing reveals high prevalence of CNS infections among people living with HIV in Zambia with CNS symptoms

There is a high prevalence of central nervous system (CNS) opportunistic infections among people living with HIV in Zambia who present with CNS symptoms, investigators report in

Published
30 April 2014
By
Michael Carter
← First12345...11Next →

Filter by country